The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 Patients

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/595fb8be9a134d50d5a25b6e42797f4a.pdf

Abstract Title

First Name *

Meritxell

Last Name *

Ibernon

Co-author 1

Meritxell Ibernon meritxell.ibernonvilaro@csi.cat Nephrology Department. Hospital Sant Joan Despí Moisès Broggi Barcelona. Spain

Co-author 2

Maru Navarro minavarrod@csi.cat Barcelona. Spain

Co-author 3

Montserrat Gomà mgoma@bellvitgehospital.cat Pathology Department. Hospital de Bellvitge Barcelona. Spain

Co-author 4

Ariel Tango atangob@csi.cat Nephrology Department. Hospital Sant Joan Despí Moisès Broggi Barcelona. Spain

Co-author 5

Oana Rap orap@csi.cat Nephrology Department. Hospital Sant Joan Despí Moisès Broggi Barcelona. Spain

Co-author 6

Cristina Cabrera ccabreral@csi.cat Nephrology Department.Hospital Sant Joan Despí Moisès Broggi Barcelona. Spain

Co-author 7

Ana Sánchez asancheze@csi.cat Nephrology Department. Hospital Sant Joan Despí Moisès Broggi Barcelona. Spain

Co-author 8

Neus Farré nrodriguezf@csi.cat Nephrology Department. Hospital Sant Joan Despí Moisès Broggi Barcelona. Spain

Co-author 9

Pilar Ruiz pruiz@csi.cat Nephrology Department. Hospital Sant Joan Despí Moisès Broggi Barcelona. Spain

Co-author 10

Meritxell Ibernon meritxell.ibernonvilaro@csi.cat Nephrology Department. Hospital Sant Joan Despí Moisès Broggi Barcelona. Spain

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15